Business · 09/04/2025Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of 18 New Drug Applications from GE HealthCare, et al.
Summary
The US Food and Drug Administration (FDA) has withdrawn the approval of 18 new drug applications from various applicants, including GE HealthCare, following notifications that the drug products are no longer commercially available.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →